Wishing you all the joys of the season! 
Middle East & Africa Poultry Vaccines Market Forecast to 2031
Middle East & Africa Poultry Vaccines Market Forecast to 2031 – Regional Analysis – by Type (Broiler and Layer), Technology (Live Attenuated Vaccines, Inactivated Vaccines, and Recombinant Vaccines), Dosage Form (Liquid Vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease (Avian Influenza, Salmonellosis, Marek’s Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Newcastle Disease, and Others), Route Of Administration (Drinking water (D/W), Intramuscular (I/M), Subcutaneous (S/C), and Others), and End User (Poultry Farms, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Growing Poultry Industry Bolster Middle East & Africa Poultry Vaccines Market
According to the US Department of Agriculture (USDA) report, poultry has become the most consumed livestock commodity worldwide in the past two decades, particularly in developing and emerging markets. Also, poultry is expected to remain the world’s largest imported livestock commodity by volume in the next 10 years as per the same USDA report. The demand for poultry products and imports is rising worldwide. As rising disposable incomes, consumers shift toward purchasing animal-based poultry products comprising high content of proteins, specifically chicken. With rapid urbanization in many developing economies and emerging markets such as Southeast Asia and Sub-Saharan Africa, poultry products provide consumers with an affordable option for purchase as poultry products comprise high protein content and are more readily available as compared to other meat-based products that are expensive. To match the demand and supply of poultry products, several countries are focusing on domestic poultry production. Further, from 2001 to 2021, global poultry imports rose to an average of 4% year-on-year (y-o-y), reaching 14.2 million metric tons of production in 2021. With poultry products remaining high in demand worldwide and countries focusing on domestic livestock production, the demand for vaccination is also growing. Thus, the growing poultry industry fuels the poultry vaccines market growth.
Middle East & Africa Poultry Vaccines Market Overview
Middle East and Africa region is divided into main countries such as Saudi Arabia, South Africa, UAE, and Rest of Middle East & Africa. In Middle East and Africa region, Saudi Arabia accounts major share for poultry vaccines market. Rising consumption pattern of protein source food is the most influential factor responsible for market growth.
Middle East & Africa Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)
Middle East & Africa Poultry Vaccines Market Segmentation
The Middle East & Africa poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.
Based on type, the Middle East & Africa poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.
In terms of technology, the Middle East & Africa poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.
By dosage form, the Middle East & Africa poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.
Based on disease, the Middle East & Africa poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held the largest market share in 2023.
In terms of route of administration, the Middle East & Africa poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.
Based on end user, the Middle East & Africa poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.
By country, the Middle East & Africa poultry vaccines market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa poultry vaccines market share in 2023.
Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB. are some of the leading companies operating in the Middle East & Africa poultry vaccines market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to Business Market Insights’ research, the Middle East & Africa poultry vaccines market was valued at US$ 68.09 million in 2023 and is anticipated to reach US$ 119.87 million by 2031, registering a CAGR of 7.3% from 2023 to 2031. Rising prevalence of poultry diseases and growing poultry industry are among the critical factors attributed to drive the Middle East & Africa poultry vaccines market growth.
Poultry production results in producing different types of animal proteins through eggs and meat. With rising poultry production, there are high chances of susceptibility to several zoonotic diseases such as “Fowl disease” that might result in huge economic losses, particularly in developing countries. For example, chickens are more prone to bacterial, viral, parasitic, and fungal infections. These viral outbreaks can cause Newcastle Disease, Avian Influenza, Infectious Bursal Disease, and other diseases in other poultry animals.
Poultry diseases are a major cause of death of chicks and also lead to reduced livestock productivity of chickens. Farmers are facing huge economic losses worldwide as they spread zoonotic diseases, posing a serious health risk to mammals. For example, poultry coccidiosis is one of the most common diseases across the globe; it leads to huge losses associated with mortality, reduced body weight, and extra expenses related to preventive and therapeutic control. As per the DSM company website, farmers face an economic loss of US$ 3 billion annually owing to coccidiosis in chickens and avian species worldwide. Newcastle disease is also considered an economically expensive disease-causing huge production losses to the farmers of developing countries that export poultry products.
Therefore, the rising prevalence of poultry diseases resulting in huge economic losses boosts the demand for poultry vaccinations, which drives the market.
On the contrary, vaccination failure and improper handling hamper the growth of Middle East & Africa poultry vaccines market.
Based on type, the Middle East & Africa poultry vaccines market is bifurcated into broiler and layer. The broiler segment held 62.7% market share in 2023, amassing US$ 42.67 million. It is projected to garner US$ 77.01 million by 2031 to register 7.7% CAGR during 2023-2031.
In terms of technology, the Middle East & Africa poultry vaccines market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held 53.3% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 36.28 million. It is projected to garner US$ 64.79 million by 2031 to register 7.5% CAGR during 2023-2031.
By dosage form, the Middle East & Africa poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held 49.3% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 33.55 million. It is projected to garner US$ 61.26 million by 2031 to expand at 7.8% CAGR from 2023 to 2031.
Based on type of disease, the Middle East & Africa poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek’s disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The Newcastle disease segment held 27.6% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 18.80 million. It is predicted to garner US$ 34.90 million by 2031 to expand at 8.0% CAGR between 2023 and 2031.
By route of administration, the Middle East & Africa poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held 40.1% share of Middle East & Africa poultry vaccines market in 2023, amassing US$ 27.30 million. It is estimated to garner US$ 50.16 million by 2031 to expand at 7.9% CAGR during 2023-2031.
In terms of end user, the Middle East & Africa poultry vaccines market is categorized into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held 50.2% share of Middle East & Africa hearing aids market in 2023, amassing US$ 34.17 million. It is projected to garner US$ 62.52 million by 2031 to expand at 7.8% CAGR from 2023 to 2031.
Based on country, the Middle East & Africa poultry vaccines market is categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that South Africa captured 71.9% share of Middle East & Africa poultry vaccines market in 2023. It was assessed at US$ 48.98 million in 2023 and is likely to hit US$ 88.33 million by 2031, registering a CAGR of 7.6% during 2023-2031.
Key players operating in the Middle East & Africa poultry vaccines market are Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, and Vaccinova AB, among others.
In January 2020, Boehringer Ingelheim has launched VAXXITEK HVT+IBD+ND. The vaccines provides a strong immune foundation and optimized protection against Marek’s Disease, Infectious Bursal Disease (classic and variant types) and Newcastle Disease.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa poultry vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa poultry vaccines market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
4. Middle East & Africa Poultry Vaccines Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Rising Prevalence of Poultry Diseases
4.1.2 Growing Poultry Industry
4.2 Market Restraints
4.2.1 Vaccination Failure and Improper Handling
4.3 Market Opportunities
4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
4.4 Future Trends
4.4.1 Advancements in Vectored and Combination Vaccines
4.5 Impact of Drivers and Restraints:
5. Middle East & Africa Poultry Vaccines Market Analysis
5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031
6. Middle East & Africa Poultry Vaccines Market Analysis – by Type
6.1 Overview
6.2 Broiler
6.2.1 Overview
6.2.2 Broiler: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
6.3 Layer
6.3.1 Overview
6.3.2 Layer: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7. Middle East & Africa Poultry Vaccines Market Analysis – by Technology
7.1 Overview
7.2 Live Attenuated Vaccines
7.2.1 Overview
7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Inactivated Vaccines
7.3.1 Overview
7.3.2 Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Recombinant Vaccines
7.4.1 Overview
7.4.2 Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa Poultry Vaccines Market Analysis – by Dosage Form
8.1 Overview
8.2 Liquid Vaccines
8.2.1 Overview
8.2.2 Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Freeze-Dried Vaccines
8.3.1 Overview
8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Dust/Powdered Vaccines
8.4.1 Overview
8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9. Middle East & Africa Poultry Vaccines Market Analysis – by Disease
9.1 Overview
9.2 Avian Influenza
9.2.1 Overview
9.2.2 Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Avian Salmonellosis
9.3.1 Overview
9.3.2 Avian Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Marek’s Disease
9.4.1 Overview
9.4.2 Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Infectious Bronchitis (IB)
9.5.1 Overview
9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Infectious Bursal Disease (IBD)
9.6.1 Overview
9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Newcastle Disease
9.7.1 Overview
9.7.2 Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10. Middle East & Africa Poultry Vaccines Market Analysis – by Route of Administration
10.1 Overview
10.2 Drinking Water (D/W)
10.2.1 Overview
10.2.2 Drinking Water (D/W): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.3 Intramuscular (I/M)
10.3.1 Overview
10.3.2 Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.4 Subcutaneous (S/C)
10.4.1 Overview
10.4.2 Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11. Middle East & Africa Poultry Vaccines Market Analysis – by End User
11.1 Overview
11.2 Poultry Farms
11.2.1 Overview
11.2.2 Poultry Farms: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Veterinary Hospitals
11.3.1 Overview
11.3.2 Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
11.4 Poultry Vaccination Centers & Clinics
11.4.1 Overview
11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12. Middle East & Africa Poultry Vaccines Market – Country Analysis
12.1 Middle East & Africa Market Overview
12.1.1 Poultry Vaccines Market Breakdown by Countries
12.1.2 Poultry Vaccines Market Revenue and Forecast and Analysis – by Country
12.1.2.1 South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.1.1 Overview
12.1.2.1.2 The table below represents the H5N8 Avian Influenza (HPAI) outbreak from June 2017 to November 2020:
12.1.2.1.3 South Africa: Poultry Vaccines Market Breakdown by Type
12.1.2.1.4 South Africa: Poultry Vaccines Market Breakdown by Technology
12.1.2.1.5 South Africa: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.1.6 South Africa: Poultry Vaccines Market Breakdown by Disease
12.1.2.1.7 South Africa: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.1.8 South Africa: Poultry Vaccines Market Breakdown by End User
12.1.2.2 Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.2.1 Overview
12.1.2.2.2 Saudi Arabia: Poultry Vaccines Market Breakdown by Type
12.1.2.2.3 Saudi Arabia: Poultry Vaccines Market Breakdown by Technology
12.1.2.2.4 Saudi Arabia: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.2.5 Saudi Arabia: Poultry Vaccines Market Breakdown by Disease
12.1.2.2.6 Saudi Arabia: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.2.7 Saudi Arabia: Poultry Vaccines Market Breakdown by End User
12.1.2.3 United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.3.1 Overview
12.1.2.3.2 United Arab Emirates: Poultry Vaccines Market Breakdown by Type
12.1.2.3.3 United Arab Emirates: Poultry Vaccines Market Breakdown by Technology
12.1.2.3.4 United Arab Emirates: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.3.5 United Arab Emirates: Poultry Vaccines Market Breakdown by Disease
12.1.2.3.6 United Arab Emirates: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.3.7 United Arab Emirates: Poultry Vaccines Market Breakdown by End User
12.1.2.4 Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
12.1.2.4.1 Overview
12.1.2.4.2 Rest of Middle East & Africa: Poultry Vaccines Market Breakdown by Type
12.1.2.4.3 Rest of Middle East & Africa: Poultry Vaccines Market Breakdown by Technology
12.1.2.4.4 Rest of Middle East & Africa: Poultry Vaccines Market Breakdown by Dosage Form
12.1.2.4.5 Rest of Middle East & Africa: Poultry Vaccines Market Breakdown by Disease
12.1.2.4.6 Rest of Middle East & Africa: Poultry Vaccines Market Breakdown by Route of Administration
12.1.2.4.7 Rest of Middle East & Africa: Poultry Vaccines Market Breakdown by End User
13. Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Poultry Vaccines Market
13.3 Organic Developments
13.3.1 Overview
13.1 Inorganic Developments
13.1.1 Overview
14. Company Profiles
14.1 Boehringer Ingelheim International GmbH
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Zoetis Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Phibro Animal Health Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Dechra Pharmaceuticals PLC
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Elanco Animal Health Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Merck KGaA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Ceva
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Vaccinova AB
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
15. Appendix
15.1 About The Research Team
15.2 Glossary of Terms
Table 1. Middle East & Africa Poultry Vaccines Market Segmentation
Table 2. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 3. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 4. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 5. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 6. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 7. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 9. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 10. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 11. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 12. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 13. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 14. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 15. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 16. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 17. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 18. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 19. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 20. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Type
Table 21. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 22. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Dosage Form
Table 23. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Disease
Table 24. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by Route of Administration
Table 25. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 26. Organic Developments Done by Companies
Table 27. Inorganic Developments Done by Companies
Table 28. Glossary of Terms, Poultry Vaccines Market
Figure 1. Middle East & Africa Poultry Vaccines Market Segmentation, by Country
Figure 2. Poultry Vaccines Market – Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
Figure 5. Poultry Vaccines Market Share (%) – by Type, 2023 and 2031
Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 8. Poultry Vaccines Market Share (%) – by Technology, 2023 and 2031
Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 12. Poultry Vaccines Market Share (%) – by Dosage Form, 2023 and 2031
Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 16. Poultry Vaccines Market Share (%) – by Disease, 2023 and 2031
Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 19. Marek’s Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 24. Poultry Vaccines Market Share (%) – by Route of Administration, 2023 and 2031
Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 29. Poultry Vaccines Market Share (%) – by End User, 2023 and 2031
Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 32. Poultry Vaccination Centers and Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
Figure 33. Middle East & Africa: Poultry Vaccines Market by Key Countries – Revenue 2023 (US$ Million)
Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 35. South Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 36. Saudi Arabia: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 37. United Arab Emirates: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 38. Rest of Middle East & Africa: Poultry Vaccines Market – Revenue and Forecast to 2031 (US$ Million)
Figure 39. Growth Strategies in the Poultry Vaccines Market
The List of Companies – Middle East & Africa Poultry Vaccines Market
o Boehringer Ingelheim International GmbH.
o Zoetis Inc.
o Phibro Animal Health Corp.
o Dechra Pharmaceuticals PLC.
o Elanco Animal Health Inc.
o Merck KGaA.
o Ceva.
o Vaccinova AB.
You must be logged in to post a review.
Reviews
There are no reviews yet.